BeiGene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About BGNE

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. 

CEO
John V. Oyler
CEOJohn V. Oyler
Employees
10,000
Employees10,000
Headquarters
George Town, George Town
HeadquartersGeorge Town, George Town
Founded
2010
Founded2010
Employees
10,000
Employees10,000

BGNE Key Statistics

Market cap
18.52B
Market cap18.52B
Price-Earnings ratio
-22.60
Price-Earnings ratio-22.60
Dividend yield
Dividend yield
Average volume
175.43K
Average volume175.43K
High today
$172.30
High today$172.30
Low today
$167.56
Low today$167.56
Open price
$168.23
Open price$168.23
Volume
255.53K
Volume255.53K
52 Week high
$245.74
52 Week high$245.74
52 Week low
$126.97
52 Week low$126.97

BGNE News

Yahoo Finance 6d
The BeiGene, Ltd. First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance

A week ago, BeiGene, Ltd. (NASDAQ:BGNE) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. The results overa...

The BeiGene, Ltd. First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Simply Wall St 7d
BeiGene First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

BeiGene ( ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net loss: US$251.2m (loss narrowed by 28% from 1Q 2023...

BeiGene First Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Analyst ratings

93%

of 27 ratings
Buy
92.6%
Hold
7.4%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.